The Economic Consequences of a Drug-Drug Interaction
Authors:
- Mujeeb U. ShadMSMujeeb U. Shad
- Connie MarshCMConnie Marsh
- Sheldon H. PreskornSPSheldon H. Preskorn
- 1 February 2001
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 21 (1) , 119-120
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Pharmacodynamic and Pharmacokinetic Factors in a Case of Neuroleptic Malignant SyndromeJournal of Clinical Psychopharmacology, 1998
- Lack of Adverse Interactions Between Concomitantly Administered Selegiline and CitalopramClinical Neuropharmacology, 1997
- Effects of the CYP2D6 genotype on the steady-state plasma concentrations of haloperidol and reduced haloperidol in Japanese schizophrenic patientsPharmacogenetics, 1997
- Interaction between fluoxetine and haloperidol: Pharmacokinetic and clinical implicationsPharmacological Research, 1997
- Involvement of CYP3A4 and CYP2D6 in the Metabolism of HaloperidolCellular and Molecular Neurobiology, 1997
- Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's diseaseNeurology, 1997
- Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental areaBritish Journal of Pharmacology, 1995
- Fluoxetine and Selegiline – Lack of Significant InteractionCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 1994